Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Table 1

Malpractice claims.

Claim	Cases (𝑛, %)	Verdict in favor of (𝑛, %)
Failure to treat with tPA	28, 70%	Of 28; Defendant: 19, 67.9%; Plaintiff: 7, 25%; NA: 2, 7.1%
Complication as a result of giving tPA	2, 5%	Of 2; Defendant: 1, 50%; Plaintiff: 1, 50%
Failure to diagnose	10, 25%	Of 10; Defendant: 6, 60%; Plaintiff: 4, 40%
Total claims	40	Defendant: 26, 65%; Plaintiff: 12, 30%; NA: 2, 5%